Impact of worst pain severity and morning fatigue profiles on oncology outpatients' symptom burden and quality of life
- PMID: 36355215
- DOI: 10.1007/s00520-022-07431-6
Impact of worst pain severity and morning fatigue profiles on oncology outpatients' symptom burden and quality of life
Abstract
Purpose: Pain and fatigue are common symptoms in oncology patients. In a sample of oncology outpatients receiving chemotherapy (n = 1342), the study purposes were to identify subgroups of patients with distinct worst pain and morning fatigue profiles and evaluate for differences among the subgroups in demographic and clinical characteristics, as well as the severity of common symptoms and quality of life (QOL) outcomes.
Methods: Oncology outpatients receiving chemotherapy (n = 1342) completed self-report questionnaires to assess pain and morning fatigue, a total of six times over two cycles of chemotherapy. Joint latent profile analysis was used to identify subgroups of patients with distinct pain and morning fatigue profiles. Differences among the classes were evaluated using parametric and non-parametric tests.
Results: Five distinct profiles were identified (no pain and low morning fatigue (27.6%), moderate pain and low morning fatigue (28.2%), moderate pain and morning fatigue (28.0%), moderate pain and increasing and decreasing morning fatigue (6.9%), severe pain and very high morning fatigue (9.3%)). Patients with the three worst profiles had clinically meaningful levels of depression and sleep disturbance and decrements in QOL.
Conclusions: Over 44% of the sample had moderate to high levels of both pain and morning fatigue. Unrelieved pain may contribute to disturbed sleep which results in higher levels of morning fatigue. Clinicians need to assess for pain and fatigue, as well as sleep disturbance during chemotherapy.
Keywords: Cancer; Chemotherapy; Fatigue; Morning fatigue; Pain; Quality of life; Sleep disturbance.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Sleep disturbance and decrements in morning energy contribute to a higher symptom burden in oncology patients.Sleep Med. 2023 Aug;108:124-136. doi: 10.1016/j.sleep.2023.06.004. Epub 2023 Jun 3. Sleep Med. 2023. PMID: 37354746
-
Distinct sleep disturbance and cognitive dysfunction profiles in oncology outpatients receiving chemotherapy.Support Care Cancer. 2022 Nov;30(11):9243-9254. doi: 10.1007/s00520-022-07350-6. Epub 2022 Sep 6. Support Care Cancer. 2022. PMID: 36066629
-
Greater Symptom Burden and Poorer Quality of Life Outcomes Are Associated With The Co-Occurrence of Anxiety and Depression During Cancer Chemotherapy.Semin Oncol Nurs. 2025 Apr;41(2):151809. doi: 10.1016/j.soncn.2025.151809. Epub 2025 Feb 13. Semin Oncol Nurs. 2025. PMID: 39952817
-
Distinct Wound Healing and Quality-of-Life Outcomes in Subgroups of Patients With Venous Leg Ulcers With Different Symptom Cluster Experiences.J Pain Symptom Manage. 2017 May;53(5):871-879. doi: 10.1016/j.jpainsymman.2016.12.336. Epub 2017 Jan 4. J Pain Symptom Manage. 2017. PMID: 28063868 Review.
-
Scoping review of common secondary conditions after stroke and their associations with age and time post stroke.Top Stroke Rehabil. 2014 Sep-Oct;21(5):371-82. doi: 10.1310/tsr2105-371. Top Stroke Rehabil. 2014. PMID: 25341382
Cited by
-
Prospective trajectories of depression predict mortality in cancer patients.J Behav Med. 2024 Aug;47(4):682-691. doi: 10.1007/s10865-024-00485-3. Epub 2024 Apr 14. J Behav Med. 2024. PMID: 38615300
-
Epigenomic Links Between Social Determinants of Health and Symptoms: A Scoping Review.Biol Res Nurs. 2023 Jul;25(3):404-416. doi: 10.1177/10998004221147300. Epub 2022 Dec 20. Biol Res Nurs. 2023. PMID: 36537264 Free PMC article.
References
-
- Al Maqbali M, Al Sinani M, Al Naamani Z, Al Badi K, Tanash MI (2021) Prevalence of fatigue in patients with cancer: a systematic review and meta-analysis. J Pain Symptom Manag 61(167–189):e114
-
- Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG (2001) AUDIT: The Alcohol Use Disorders Identification Test: guidelines for use in primary care. World Health Organization, Geneva, Switzerland
-
- Barbour KE, Helmick CG, Boring M, Zhang X, Lu H (2014) Holt JB (2016) Prevalence of doctor-diagnosed arthritis at state and county levels - United States. MMWR Morb Mortal Wkly Rep 65:489–494 - DOI
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical